Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The AMME chromosomal region gene 1-like protein (AMMECR1L) is a nuclear protein predicted to play a modulatory role in nuclear processes, particularly as a paralog of AMMECR1. It contains a nucleic acid–binding RAGNYA fold and is known to dimerize in the nucleus. Evidence suggests that AMMECR1L may partially compensate for loss of AMMECR1 function, shown by increased AMMECR1L mRNA and protein in patients with AMMECR1 loss-of-function. This protein may regulate cell cycle events and gene expression control, with altered expression noted in renal cell carcinoma. However, its specific molecular function, implications as a therapeutic target, and drug interactions remain uncharacterized as of current data[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on AMME chromosomal region gene 1-like protein (AMMECR1L).